LipoScience Priced, Nasdaq: LPDX
Provides an LDL diagnostic test to assess cardiovascular disease risk.
Industry: Health Care
First Day Return: +16.1%
Industry: Health Care
LPDX
Provides an LDL diagnostic test to assess cardiovascular disease risk.
| IPO Data | |
|---|---|
| IPO File Date | 06/23/2011 |
| Offer Price | $9.00 |
| Price Range $9.00 - $10.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $45 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 01/24/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $45 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Raleigh, NC, United States |
| Founded | 1997 |
| Employees at IPO | 204 |
| Website www.liposcience.com | |
IPO News for LipoScience
LipoScience (LPDX) Performance
